Century Therapeutics, Inc. (IPSC)
NASDAQ: IPSC · Real-Time Price · USD
0.5008
-0.0175 (-3.38%)
At close: Sep 12, 2025, 4:00 PM EDT
0.5187
+0.0179 (3.57%)
Pre-market: Sep 15, 2025, 4:51 AM EDT

Century Therapeutics Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 20202019
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019
114.136.592.245.2--
Upgrade
Revenue Growth (YoY)
5491.77%194.81%-57.01%---
Upgrade
Cost of Revenue
110.04107.2492.7197.1775.65-
Upgrade
Gross Profit
4.09-100.66-90.48-91.97-75.65-
Upgrade
Selling, General & Admin
32.7434.5134.7131.8619.249.5
Upgrade
Research & Development
-----39.68
Upgrade
Operating Expenses
32.7434.5134.7131.8619.2449.18
Upgrade
Operating Income
-28.66-135.17-125.18-123.83-94.88-49.18
Upgrade
Interest Expense
---0.54-1.43-1.28-0.38
Upgrade
Interest & Investment Income
10.6213.0112.684.420.380.7
Upgrade
Other Non Operating Income (Expenses)
0.430.35-0.38---
Upgrade
EBT Excluding Unusual Items
-17.61-121.81-113.43-120.84-95.78-48.85
Upgrade
Impairment of Goodwill
-4.33-4.33----
Upgrade
Asset Writedown
---16.37---
Upgrade
Other Unusual Items
0.431.36----
Upgrade
Pretax Income
-21.51-124.78-134.79-130.84-95.78-53.58
Upgrade
Income Tax Expense
1.771.791.880.090.04-
Upgrade
Net Income
-23.28-126.57-136.67-130.93-95.82-53.58
Upgrade
Net Income to Common
-23.28-126.57-136.67-130.93-95.82-53.58
Upgrade
Shares Outstanding (Basic)
86795958327
Upgrade
Shares Outstanding (Diluted)
86795958327
Upgrade
Shares Change (YoY)
29.80%32.60%2.70%78.30%332.95%10.43%
Upgrade
EPS (Basic)
-0.27-1.61-2.30-2.27-2.96-7.16
Upgrade
EPS (Diluted)
-0.27-1.61-2.30-2.27-2.96-7.16
Upgrade
Free Cash Flow
-114.91-110.29-102.08-16.55-133.97-51.09
Upgrade
Free Cash Flow Per Share
-1.34-1.40-1.72-0.29-4.14-6.83
Upgrade
Operating Margin
-25.11%-2051.39%-5600.94%-2381.82%--
Upgrade
Profit Margin
-20.40%-1920.87%-6115.12%-2518.41%--
Upgrade
Free Cash Flow Margin
-100.69%-1673.84%-4567.52%-318.37%--
Upgrade
EBITDA
-15.62-121.86-112.14-115.39-91.14-47.77
Upgrade
D&A For EBITDA
13.0413.313.048.443.751.4
Upgrade
EBIT
-28.66-135.17-125.18-123.83-94.88-49.18
Upgrade
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q